3171 results for «3379»
3171 results
The five most impactful trials of 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead of the curve by exploring the five most impactful cardiovascular intervention trials of 2024. Gain insights into the latest evidence that can transform your clinical practice. Analyze the methodology and applicability of these groundbreaking studies, and learn how to seamlessly integrate them into your...
Mechanical circulatory support: role in the management of high-risk PCI and AMI-cardiogenic shock
19 Dec 2024 – From GulfPCR-GIM 2024
This session highlights the essential role of mechanical circulatory support (MCS) in managing high-risk PCI and AMI-related cardiogenic shock. Explore case-based discussions on device selection, hemodynamic impact, and evidence-based strategies to optimize outcomes in complex scenarios.
Training and well-being: how to make the cathlab an attractive place to work
19 Dec 2024 – From GulfPCR-GIM 2024
Discover strategies to transform the cath lab into an attractive and rewarding work environment. This session delves into the crucial aspects of training new colleagues and cultivating a positive well-being culture. Learn effective techniques to onboard and develop your team, ensuring they not only excel in...
Challenging structural interventions #2
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this session on challenging structural interventions, covering critical topics such as when to transition from the cath lab to the operating room, considerations around post-dilation when performing valve-in-valve procedures, strategies for preventing complications in TAVI for bicuspid aortic valve and coarctation of the aorta, as...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead in TAVI innovation by exploring the advanced balloon-expandable Myval THV series. This session highlights the latest clinical data, optimal sizing and implantation techniques, and valuable real-world insights, including long-term follow-up results.
Renal denervation in 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Join us to explore advancements in renal denervation (RDN) technology and clinical applications. This session covers radiofrequency and ultrasound approaches, mechanisms, step-by-step procedures, patient selection, and program setup, offering insights into optimizing outcomes for hypertension patients.
Please note that this Case-in-a-Box does not reflect the recording standards...
When complications storm through the cathlab #2
19 Dec 2024 – From GulfPCR-GIM 2024
Brace yourself as we delve into a captivating session showcasing a series of complex and challenging complications that can arise in the catheterization laboratory. From a coiling gone awry to a stuck burr in an elderly patient, this session offers invaluable insights and strategies for navigating...
Complications and challenging cases #2
19 Dec 2024 – From GulfPCR-GIM 2024
Dive into this session to explore a collection of challenging cases and complications encountered in interventional cardiology. From a ruptured balloon inside a coronary artery to a percutaneous ventricular septal rupture closure post myocardial infarction, uncover the strategies and techniques used to manage these complex situations....
Left main PCI strategies for bifurcations and trifurcations
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this comprehensive session on left main PCI strategies for bifurcations and trifurcations. Discover techniques such as the triple kissing balloon inflation technique in a complex distal LM trifurcation lesion, imaging-guided multivessel PCI to left anterior descending CTO and left main bifurcation, and IVUS-guided PCI to...
Caught between a calcified rock and a hard place
19 Dec 2024 – From GulfPCR-GIM 2024
This session delves into the challenges of managing heavily calcified coronary lesions, particularly in complex scenarios like left main bifurcation angioplasty and in elderly patients with unstable angina. Explore innovative techniques to tackle abrupt vessel closure, situations where rotablation may fall short, and state-of-the-art approaches for...
GulfPCR-GIM 2024 Opening Ceremony
18 Dec 2024 – From GulfPCR-GIM 2024
The GulfPCR-GIM 2024 opening ceremony, live from Dubai, marks the start of this year’s premier interventional course in the Middle East. Building on the success of last year, which gathered over 1,100 participants and featured 50+ sessions, the 2024 edition promises an even richer program. Highlights...
New technology for transcather valve replacement - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a series of recorded cases showcasing advanced valve therapies and innovative techniques:
- A 70-year-old man with Marfan syndrome (treated by Bentall and CABG in 2012), impaired LV function (35%), CRT-D, and symptomatic severe primary MR (A2 prolapse with calcification) underwent implantation of an Intrepid valve under...
Imaging-based strategies for complication management in STEMI
21 May 2025 – From EuroPCR 2025
Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
TAVI for aortic regurgitation: on-label and off-label use
21 May 2025 – From EuroPCR 2025
This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.
Treatment dilemmas in STEMI patients with multivessel disease
21 May 2025 – From EuroPCR 2025
Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
